Sanofi recently reported late-stage trial results showing its experimental eczema drug amlitelimab met key endpoints in multiple phase 3 studies and will be submitted for global regulatory review as a ...

The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

A vaccine created by University of Georgia researchers to battle multiple life-threatening fungal infections is also ...

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...

Michael Rahe, an assistant professor of immunology at the North Carolina State College of Veterinary Medicine, has been ...

GSK (GSK.L) signed a definitive agreement to purchase US-based clinical-stage biopharmaceutical company Rapt Therapeutics for ...

Researchers have harnessed AI to expedite the creation of lightbulb-like intrabody probes that can track activity in living ...

The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically ...

Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with ...

Harbour BioMed announced its wholly owned subsidiary is exercising a warrant agreement to acquire common stock in Spruce ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...